We are live on ! Find out more

9 hedge funds and large institutions have $937K invested in iBio in 2014 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

61% more capital invested

Capital invested by funds: $581K → $937K (+$356K)

0% more funds holding

Funds holding: 99 (0)

0% more ownership

Funds ownership: 0%0% (+0%)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

Holders
9
Holders Change
Holders Change %
0%
% of All Funds
0.26%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
2
Reduced
1
Closed
3
Calls
Puts
Net Calls
Net Calls Change

IBIO Hedge Fund Activity: Q3 2014 in Review

9 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in iBio (IBIO) for Q3 2014, worth a combined $937K — up 61% from $581K a quarter earlier.

Fund positioning in IBIO was balanced in Q3 2014: 3 funds opened new positions, 3 closed out, 2 added to existing stakes and 1 trimmed.

The largest buyer was Geode Capital Management, adding an estimated $97.6K. The largest seller was Dimensional Fund Advisors, exiting entirely with an estimated $52K sold.

  • 9 institutional investors held iBio (IBIO) as of Q3 2014, unchanged from Q2 2014.
  • Funds reported $937K of iBio stock for Q3 2014, up 61% quarter-over-quarter.
  • 3 funds opened new iBio positions in Q3 2014 and 3 closed out, a net change of 0 holders.
  • The largest iBio buyer in Q3 2014 was Geode Capital Management, an estimated $97.6K added.
  • The largest iBio seller in Q3 2014 was Dimensional Fund Advisors, an estimated $52K sold.

Based on aggregated 13F filings for Q3 2014.